Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20, following its move from the NYSE. Companies often change listings for better alignment with investor bases or to reduce costs.
Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20, following its move from the NYSE. Companies often change listings for better alignment with investor bases or to reduce costs.